Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013/ALFQ in rhesus macaques (Macaca mulatta) of Indian and Chinese origin

Fig. 3

Antibody titer and function: mean ELISA titers at 2 weeks post 1st (2WP1), 4WP1, 4WP2 and 2WP3 against, a FMP013 antigen; b (NANP) × 6 repeat antigen. Individual animal and at 2 weeks post 3rd dose showing; c NPNA ELISA titers; d NPNA antibody avidity index; e inhibition of liver stage development (ILSDA) assay performed at 1:200 serum dilution (4 replicates per sample). Bars represent group mean  ±  SEM (n  =  6)

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us